175 related articles for article (PubMed ID: 24216689)
1. The burden of comedication among patients with inflammatory bowel disease.
Buckley JP; Kappelman MD; Allen JK; Van Meter SA; Cook SF
Inflamm Bowel Dis; 2013 Dec; 19(13):2725-36. PubMed ID: 24216689
[TBL] [Abstract][Full Text] [Related]
2. Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics.
Haapamäki J; Tanskanen A; Roine RP; Blom M; Turunen U; Mäntylä J; Färkkilä MA; Arkkila PE
Scand J Gastroenterol; 2013 Jan; 48(1):42-50. PubMed ID: 23163864
[TBL] [Abstract][Full Text] [Related]
3. International variation in medication prescription rates among elderly patients with inflammatory bowel disease.
Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD
J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of chronic narcotic use among children with inflammatory bowel disease.
Buckley JP; Cook SF; Allen JK; Kappelman MD
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):310-315.e2. PubMed ID: 25117776
[TBL] [Abstract][Full Text] [Related]
5. Narcotic use for inflammatory bowel disease and risk factors during hospitalization.
Long MD; Barnes EL; Herfarth HH; Drossman DA
Inflamm Bowel Dis; 2012 May; 18(5):869-76. PubMed ID: 21739533
[TBL] [Abstract][Full Text] [Related]
6. Increased Use of Medications for Erectile Dysfunction in Men With Ulcerative Colitis and Crohn's Disease Compared to Men Without Inflammatory Bowel Disease: A Nationwide Cohort Study.
Friedman S; Magnussen B; OʼToole A; Fedder J; Larsen MD; Nørgård BM
Am J Gastroenterol; 2018 Sep; 113(9):1355. PubMed ID: 29988041
[TBL] [Abstract][Full Text] [Related]
7. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
Metge CJ; Blanchard JF; Peterson S; Bernstein CN
Am J Gastroenterol; 2001 Dec; 96(12):3348-55. PubMed ID: 11774948
[TBL] [Abstract][Full Text] [Related]
8. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977-2013.
Kantsø B; Simonsen J; Hoffmann S; Valentiner-Branth P; Petersen AM; Jess T
Am J Gastroenterol; 2015 Nov; 110(11):1582-7. PubMed ID: 26346865
[TBL] [Abstract][Full Text] [Related]
10. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011.
Rungoe C; Langholz E; Andersson M; Basit S; Nielsen NM; Wohlfahrt J; Jess T
Gut; 2014 Oct; 63(10):1607-16. PubMed ID: 24056767
[TBL] [Abstract][Full Text] [Related]
11. Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease.
Geisz M; Ha C; Kappelman MD; Martin CF; Chen W; Anton K; Sandler RS; Long MD
Inflamm Bowel Dis; 2016 Jun; 22(6):1435-41. PubMed ID: 26978725
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population.
Betteridge JD; Armbruster SP; Maydonovitch C; Veerappan GR
Inflamm Bowel Dis; 2013 Jun; 19(7):1421-7. PubMed ID: 23518811
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
[TBL] [Abstract][Full Text] [Related]
14. Cannabis use amongst patients with inflammatory bowel disease.
Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
16. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database.
Kurti Z; Vegh Z; Golovics PA; Fadgyas-Freyler P; Gecse KB; Gonczi L; Gimesi-Orszagh J; Lovasz BD; Lakatos PL
Dig Liver Dis; 2016 Nov; 48(11):1302-1307. PubMed ID: 27481587
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.
Ludvigsson JF; Büsch K; Olén O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
BMC Gastroenterol; 2017 Jan; 17(1):23. PubMed ID: 28143594
[TBL] [Abstract][Full Text] [Related]
18. Anemia in a population-based IBD cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients.
Sjöberg D; Holmström T; Larsson M; Nielsen AL; Holmquist L; Rönnblom A
Inflamm Bowel Dis; 2014 Dec; 20(12):2266-70. PubMed ID: 25268635
[TBL] [Abstract][Full Text] [Related]
19. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.
Storr M; Devlin S; Kaplan GG; Panaccione R; Andrews CN
Inflamm Bowel Dis; 2014 Mar; 20(3):472-80. PubMed ID: 24407485
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of pain medication prescriptions in France, Germany, and the UK - a cross-sectional study including 4,270,142 patients.
Jacob L; Kostev K
Postgrad Med; 2018 Jan; 130(1):32-36. PubMed ID: 29022417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
